DailyIQ
Last updated1 minute ago

DOC·Healthpeak Properties, Inc.

$19.01
+0.17 (+0.90%)
After Hours
High
$19.18
Open
$18.86
Market Cap
13.31B
52W High
$23.00
Low
$18.80
P. Close
$19.01
P/E
54.71
52W Low
$15.70
Fwd P/E
134.57
DailyIQ Est.
$23.23
Inst. Ownership
48.7%
Short Interest
3.62%
Days to Cover
6.3
Technical Score (1D)
0
BEARISH
News Sentiment
43
BEARISH
On Oct 5, Healthpeak Properties was slated to report its Q3 earnings, with analysts projecting a single‑digit year‑over‑year decline in earnings per share. The forecasted drop reflected a modest contraction in revenue and operating income compared to the prior year. Despite the decline, the company had consistently beat earnings estimates in the previous four quarters, indicating resilience in its core operations. The guidance suggested that the decline would be contained and unlikely to trigger a significant market reaction. The report highlighted that the forecasted headwind was viewed as mild rather than a material setback.
LOW TARGET
$17 -10.5%
2 analysts
MEAN TARGET
$23 +20.8%
19 analysts
HIGH TARGET
$29 +52.6%
7 analysts
PRICE RANGE
$17.00 - $29.00
SB / B / H / S / SS
4/6/16/1/1
DAILYIQ EST.
$23.23 (+22.3%)
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Exchange
NYQ
Country
United States
Symbol
DOC
Description
Healthpeak Properties, Inc. is a U.S.-based real estate investment trust (REIT) focused on the healthcare sector. Established in 1985 and structured as an umbrella partnership REIT, the company concentrates on owning, operating, and developing high-quality properties primarily within outpatient medical, lab, and continuing care retirement community (CCRC) segments. Healthpeak's portfolio comprises 703 properties, including outpatient medical buildings, hospitals, lab buildings, and CCRCs. The company's operations are conducted through its operating subsidiary, Healthpeak OP, and it maintains a geographically diverse presence with headquarters in Denver, Colorado, and additional offices and property management locations across the country. Healthpeak also holds interests in joint ventures and other non-reportable segments, further diversifying its real estate holdings.
Bought (1Y)
0 shares
$0
Sold (1Y)
470 shares
$9K
Brinker Scott MPresident and CEO
Tax Withholding114 shares2026-05-29
Brinker Scott MPresident and CEO
Award/Grant1,347 shares2026-05-29
Johnston Shawn GEVP and CAO
Tax Withholding76 shares2026-05-29
Johnston Shawn GEVP and CAO
Award/Grant1,358 shares2026-05-29
Mabry Adam GCIO
Tax Withholding43 shares2026-05-29
74/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
11.8%
Revenue CAGR
-2.5%
Debt / Equity
1.31x
Return on Equity
1.0%
Earnings Summary
Healthpeak Properties, Inc. (DOC) is a U.S.-based real estate investment trust that specializes in healthcare facilities, owning and operating outpatient medical, laboratory, and continuing care retirement community properties across a geographically diverse portfolio of 703 assets. The REIT operates through its subsidiary Healthpeak OP and maintains a strong presence in the healthcare real estate sector, which has historically shown resilience amid broader market volatility. In the most recent quarters, DOC reported Q4 2025 revenue of $719.4 million, up from $698.4 million in Q4 2024, while EPS surged from $0.0508 to $0.47, reflecting a significant earnings turnaround. Q2 2026 revenue reached $771.58 million, a 6.3% increase over Q2 2025, and EPS climbed to $0.46 from $0.06172, indicating continued earnings acceleration. The REIT has consistently beat analyst expectations in the last four quarters, with EPS exceeding estimates in Q1, Q2, Q4 2025, and Q2 2026, and revenue growth maintained despite the absence of estimates for most periods. Historically, DOC has posted steady year-over-year revenue growth, with EPS improving in most periods even when revenue growth slowed, demonstrating operational efficiency and effective cost management. Recent news highlights include a September 24 guidance upgrade, where management raised its 2026 adjusted funds from operations outlook and same-store cash‑adjusted NOI growth expectations following a stronger-than-expected Q2 performance, signaling confidence in cash flow resilience. The company also announced a monthly common‑stock dividend of $0.10167 for Q4 2026, underscoring its commitment to shareholder returns.

EPS

EstBeatMiss
$-0.28$-0.07$0.14$0.36$0.57Q1'25Q2'25Q3'25Q4'25Q2'26Q3'26
QtrEstActual+/−
Q3'26$0.03 - -
Q2'26$0.03$0.46+1302.4%
Q4'25$0.06$0.47+721.7%
Q3'25$0.06$-0.18-403.2%
Q2'25$0.06$0.06+12.2%
Q1'25$0.04$0.06+40.7%

Revenue

EstBeatMiss
$665M$695M$725M$755M$786MQ1'25Q2'25Q3'25Q4'25Q2'26Q3'26
QtrEstActual+/−
Q3'26$742M - -
Q2'26$727M$772M+6.2%
Q4'25$698M$719M+3.0%
Q3'25 - $690M -
Q2'25 - $679M -
Q1'25 - $687M -

Market Data

DOC Stock Snapshot

BEARISH0/100
$19.00−$0.01 (0.1%)
Market cap
13.31B
P/E ratio
54.7
Day range
$18.80 – $19.18
News sentiment
43/100 · Neutral
Analyst target
$22.95 (+20.8%)
Consensus
Hold · 28 analysts
52-week range+21.0% off low · -17.4% from high
$15.70$23.00
Price $19.00 DailyIQ Est. $23.23

The signals on DOC lean bearish, and the range position backs that up. Sector peers are worth watching - large caps in Real Estate tend to move together on rotation.

Behaviour On Record

What DOC's own history says about today's numbers

Realized volatility (21d)
22.5% 46th pct
Below its peak
-57.7%
vs 200-day average
-0.3%
Up days (1y)
45%

Healthpeak Properties, Inc. is currently running 22.5% annualised volatility over the last 21 sessions. Measured against DOC's own 13 years of daily returns rather than a market-wide average, that is the 46th percentile — close to its own typical level, against a typical reading of 23.1%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

DOC is trading -57.7% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -24.9%, and the deepest was -46.6% in 2020. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -0.3% from its 200-day moving average. Against every other day in its history, that gap ranks at the 55th percentile — close to the gap it normally carries. Over the past year DOC closed higher on 45% of sessions, and it is currently 1 session into a falling streak.

On October specifically: over 13 years of records, DOC finished the month higher 6 of 13 times, with a median return of -0.1% and an average of -0.2%. Its strongest month historically has been July at +3.0% on average, its weakest February at -6.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: DOC has opened more than 2% away from the prior close in 153 of 3,267 sessions (4.7% of the time), with the largest gaps running +8.1% and -9.8%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

All figures computed from 3,268 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against DOC's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of DOC's sector?

Healthpeak Properties, Inc. sits in the Real Estate sector, currently ranked 11th of 12 GICS sectors by relative-strength rotation score (lagging).

Sector rank
#11 of 12
Sector state
Lagging
Sector rotation score
18

Options Market

What is the options market pricing for DOC?

CallsPuts

For Healthpeak Properties, Inc.'s nearest expiry (2026-10-16, 10 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.15), with at-the-money implied volatility around 31.4%. The options market is pricing roughly a ±6.8% move by that expiry — a range of about $19.40–$22.23.

Put/call ratio (2026-10-16)
0.15
ATM implied volatility
31.4%
Total open interest
4,655
Expected move by 2026-10-16
±6.8% ($19.40–$22.23)

Analyst Rating Changes

Are analysts turning bullish or bearish on DOC?

Evercore ISI Group most recently reiterated its rating on Healthpeak Properties, Inc. to In-Line on Sep 21, 2026 with a price target of $22 (from $23). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Evercore ISI Group — In-Line
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Sep 21, 2026Evercore ISI GroupMaintainedIn-Line$23 → $22
Aug 31, 2026BarclaysMaintainedEqual-Weight$23 → $24
Aug 13, 2026BairdMaintainedOutperform$21 → $24
Aug 11, 2026CitigroupMaintainedNeutral$20 → $22
Aug 10, 2026RBC CapitalMaintainedOutperform$21 → $24
Aug 6, 2026Cantor FitzgeraldMaintainedNeutral$20 → $23
Jul 15, 2026Wells FargoMaintainedEqual-Weight$20 → $22
Jul 8, 2026UBSMaintainedNeutral$19 → $22
Jul 7, 2026BarclaysInitiatedOverweight → Equal-Weight$23
Jul 6, 2026MizuhoMaintainedOutperform$21 → $24
Jun 24, 2026JP MorganMaintainedNeutral$18 → $21
Jun 15, 2026BMO CapitalMaintainedOutperform$20 → $24

DOC Competitive Positioning

Healthpeak Properties, Inc. (DOC) is tracked alongside these names in REIT - Healthcare Facilities on DailyIQ — ranked by market cap, with today's move alongside.

News Sentiment Analysis

Sentiment gathered from recent headlines

43/100
Strong NegativeNeutralStrong Positive
BEARISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Healthpeak Properties (DOC) was slated to report Q3 earnings on Oct. 5, 2026, with analysts projecting a single‑digit year‑over‑year decline in EPS. The forecasted drop reflected a modest contraction in revenue and operating income compared to the prior year. Despite the decline, the company had consistently beat earnings estimates in the past four quarters, suggesting resilience in its core operations. The guidance indicated that the decline would be contained and unlikely to trigger a significant market reaction.
What did this article say?
Healthpeak Properties, Inc. (DOC) announced that it would report its third‑quarter 2026 financial results on November 2, 2026, following the market close. A conference call and webcast were scheduled for November 3, 2026, to discuss the results and operating performance. The company provided dial‑in and webcast details and noted that a replay would be available until December 3, 2026. The announcement was a routine disclosure of upcoming earnings events.
What did this article say?
Healthpeak Properties, Inc. (DOC) announced on October 1, 2026 that its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the fourth quarter of 2026. The dividend translates to an annualized payout of $1.22 per share. The payment dates and record dates were specified in the company’s filing. This routine dividend declaration is a standard corporate action with no immediate impact on the company’s financial outlook or valuation.
What did this article say?
Healthpeak Properties, Inc. announced a raise in its 2026 adjusted funds from operations guidance and an upward revision of same‑store cash‑adjusted NOI growth after stronger‑than‑expected Q2 results. The upgrade signals management’s confidence in the REIT’s operating performance and suggests improved cash‑flow resilience. The move is expected to enhance the company’s risk‑return profile and may attract additional investor interest.
What did this article say?
Healthpeak Properties, ticker DOC, announced that it would convert portfolio sales into higher guidance for 2026, citing strong demand and a robust portfolio. The company highlighted that the sale proceeds would be reinvested to support growth initiatives and enhance shareholder returns. Analysts noted that the move signals confidence in the company’s ability to generate cash and maintain high dividend yields. The guidance upgrade reflects a positive outlook for the healthcare REIT sector and positions DOC favorably against peers.
What did this article say?
Healthpeak Properties (DOC) increased its 2026 adjusted funds from operations guidance following solid Q2 results, indicating a stronger future cash flow profile. The company also lifted expectations for same‑store cash adjusted NOI growth, reinforcing confidence in its operating performance. Despite a recent one‑month pullback, the guidance upgrade suggests that the stock may still offer value to investors. The update underscores DOC’s positioning as a resilient real estate investment trust with growing cash generation.
What did this article say?
Healthpeak Properties (DOC) has a market cap of $14.3 billion and operates roughly 700 outpatient and life‑science properties across the U.S. The stock has declined 10.2% from its 52‑week high and lagged the S&P 500 over the past three months, though it has posted a 28.1% year‑to‑date gain. The company’s strategy focuses on accretive growth, strong tenant partnerships, and disciplined capital allocation. No new guidance or material events were disclosed, so the performance comparison provides only a neutral context for DOC’s valuation.
What did this article say?
Evercore ISI Group’s analyst James Kammert has kept Healthpeak Properties (DOC) on an in‑line rating but reduced the price target from $23 to $22. The downgrade reflects a modest view that the company’s valuation is slightly over‑priced relative to peers. The change is largely a technical adjustment and does not signal a fundamental shift in DOC’s business outlook.
What did this article say?
Evercore ISI lowered its price target for Healthpeak Properties (DOC) from $23 to $22 while keeping an in‑line rating. The adjustment reflects a modest reassessment of the company’s valuation but does not signal a downgrade.
What did this article say?
Healthpeak Properties (DOC) announced its Q2 results on August 4, lifting its 2026 full‑year EPS guidance to $0.48‑$0.52 from $0.46‑$0.50 and adjusting FFO to $1.73‑$1.77. The upgrade reflects robust leasing activity, with 1.6 million square feet of new and renewal outpatient and lab space signed, and occupancy gains of 20 bps in outpatient and 80 bps in labs. The company’s portfolio performance suggests a healthy demand environment and positions DOC for continued earnings growth.

Technical Analysis

Real-time indicators across multiple timeframes

0
BEARISH
Technical indicators reflect the latest computed signal mix for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $6.67B combined position · 12 adding, 12 trimming, 1 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▼ Sell109,044,44215.56%$1.75B2026-01-29
BlackRock, Inc.▼ Sell70,935,04610.13%$1.52B2026-08-07
JPMorgan Chase & Co▼ Sell30,192,3174.31%$661.02M2026-08-12
Geode Capital Management, LLC▲ Buy24,653,6173.52%$526.87M2026-08-12
Invesco Ltd.▼ Sell18,507,9972.64%$396.07M2026-08-14
Morgan Stanley▲ Buy14,189,2182.03%$303.65M2026-08-13
Goldman Sachs Group Inc▲ Buy11,530,5311.65%$246.75M2026-08-14
Bank of America Corp▼ Sell10,962,6041.56%$234.60M2026-08-14
FMR LLC (Fidelity)▲ Buy10,515,6121.50%$225.03M2026-08-13
Norges Bank▼ Sell9,414,3201.34%$201.47M2026-08-12
Northern Trust Corp▼ Sell7,137,1981.02%$152.74M2026-08-13
Citadel Advisors LLC• Hold6,376,2930.91%$136.45M2026-09-02
Two Sigma Investments, LP▲ Buy2,659,4310.38%$56.91M2026-08-14
Citigroup Inc▼ Sell1,690,2090.24%$36.17M2026-08-03
Susquehanna International Group, LLP▲ Buy1,481,2220.21%$31.70M2026-08-14
AQR Capital Management LLC▲ Buy1,468,8130.21%$31.43M2026-08-14
Wells Fargo & Company▼ Sell1,261,6450.18%$27.00M2026-08-14
Neuberger Berman Group LLC▲ Buy1,106,0600.16%$23.67M2026-08-13
Squarepoint Ops LLC▲ Buy861,3540.12%$18.43M2026-08-14
Renaissance Technologies LLC▲ Buy845,9680.12%$18.10M2026-08-13
AllianceBernstein L.P.▲ Buy1,053,8480.15%$17.31M2026-08-14
Gotham Asset Management, LLC▲ Buy661,5350.09%$14.16M2026-08-14
Millennium Management LLC▼ Sell642,3050.09%$13.75M2026-08-14
Davis Selected Advisers▼ Sell631,0260.09%$13.50M2026-08-11
Adage Capital Partners GP, L.L.C.▼ Sell614,4430.09%$13.15M2026-08-14
Q2 2026 flow:11.17M sh bought ($238.93M)28.12M sh sold ($608.91M)net -16.95M sh (−$369.98M)
Congressional Trading Activity
7 disclosed trades · ~$56.0K est. traded value · 3 buys, 4 sells
MemberChamberStateTypeAmountTradedFiled
Alan ArmstrongSenateOK▲ Buy$1K - $15K2026-03-272026-07-21
Gilbert CisnerosHouseCA31▼ Sell$1K - $15K2026-02-102026-03-09
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2026-01-092026-02-13
Lisa McClainHouseMI09▼ Sell$1K - $15K2025-08-042025-09-12
Lisa McClainHouseMI09▲ Buy$1K - $15K2025-06-172025-08-13
Rob BresnahanHousePA08▼ Sell$1K - $15K2025-05-152025-06-09
Julie JohnsonHouseTX32▼ Sell$1K - $15K2025-04-012025-05-14